| Dr Lynne A Skaryak, MD | |
|
260 N 7th St, Chambersburg, PA 17201-1722 | |
| (717) 262-4660 | |
| (717) 263-6251 |
| Full Name | Dr Lynne A Skaryak |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery |
| Experience | 35 Years |
| Location | 260 N 7th St, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114966033 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
In a recent groundbreaking bioRxiv paper, Chinese researchers describe a novel approach towards coronavirus disease (COVID-19) vaccine design based on engineered human mesenchymal stem cells, with favorable and promising antibody response.
Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
Morphotek, Inc., a subsidiary of Eisai Co., Ltd., has announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the development of therapeutic antibodies to a cancer-associated protein identified by NCI researchers.
› Verified 2 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
In a recent groundbreaking bioRxiv paper, Chinese researchers describe a novel approach towards coronavirus disease (COVID-19) vaccine design based on engineered human mesenchymal stem cells, with favorable and promising antibody response.
Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
Morphotek, Inc., a subsidiary of Eisai Co., Ltd., has announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the development of therapeutic antibodies to a cancer-associated protein identified by NCI researchers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynne A Skaryak, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 262-4660 | Dr Lynne A Skaryak, MD 260 N 7th St, Chambersburg, PA 17201-1722 Ph: (717) 262-4660 |
News Archive
In a recent groundbreaking bioRxiv paper, Chinese researchers describe a novel approach towards coronavirus disease (COVID-19) vaccine design based on engineered human mesenchymal stem cells, with favorable and promising antibody response.
Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.
A study from the Journal of the American College of Nutrition (JACN) discusses fluid intake adequacy in detail and a simple tool is reviewed that may help healthy, active, low-risk populations answer the question, "Am I drinking enough?" The article "Am I Drinking Enough? Yes, No, and Maybe" by Samuel N. Cheuvront PhD, RD and Robert W. Kenefick PhD is made available with Free Access in JACN Issue 35(2) 2016, the official publication of the American College of Nutrition.
Morphotek, Inc., a subsidiary of Eisai Co., Ltd., has announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the development of therapeutic antibodies to a cancer-associated protein identified by NCI researchers.
› Verified 2 days ago